1-20 of 155 results for subject:"Vaccine Taskforce"
Librarians' tools
- Search time
- 0.384 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:"Vaccine Taskforce"
- We searched for
- subject_t:"Vaccine Taskforce" OR subject_t:"Vaccine Task Force" OR subject_ses:470105
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask His Majesty's Government, with regard to the speech by the Chief Secretary to the Prime Minister on 20 January, whether external recruitment will take place for the new taskforces modelled on the Vaccine Taskforce.
To ask His Majesty's Government, with regard to the speech by the Chief Secretary to the Prime Minister on 20 January, whether external recruitment will take place for the new taskforces modelled on the Vaccine Taskforce.
Taskforces focus on Prime Ministerial priorities and will remove obstacles to delivery, drawing on lessons from the Vaccine Taskforce and other relevant examples.
They will have the freedom to hire the best talent from within the civil service at pace and expedited approvals for short-term appointments of external expertise.
Departmental Ministers will be accountable for their policy areas as now and will have a direct line to the top of government in Number 10, the Cabinet Office, and the Treasury to help support delivery.
To ask His Majesty's Government, with regard to the speech by the Chief Secretary to the Prime Minister on 20 January, whether the budgets for the new taskforces modelled on the Vaccine Taskforce will come from existing budgets; and how many new taskforces will be created.
To ask His Majesty's Government, with regard to the speech by the Chief Secretary to the Prime Minister on 20 January, whether the budgets for the new taskforces modelled on the Vaccine Taskforce will come from existing budgets; and how many new taskforces will be created.
Number 10 and the Cabinet Office are continuing to work together and with departments to consider a range of options for Taskforces across the Prime Minister’s priorities, and will determine how many will be created.
They will be funded from existing budgets with prioritised business case approvals and increased delegated authority limits, if necessary, from the Treasury.
Departmental Ministers will remain accountable for their policy areas and will have a direct line to the top of government in Number 10, the Cabinet Office, and the Treasury to help support delivery.
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that lessons learned from the COVID-19 Vaccine Taskforce will inform its approach to managing the shortages of pancreatic enzyme replacement therapy (PERT).
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that lessons learned from the COVID-19 Vaccine Taskforce will inform its approach to managing the shortages of pancreatic enzyme replacement therapy (PERT).
The Department has not conducted a 360-degree supply and demand forecast for pancreatic enzyme replacement therapy (PERT). However, the Department is in regular discussion with suppliers of PERT on the latest stock availability and the actions that are being taken to mitigate the supply issue, including what steps suppliers are taking to ensure future supplies meet the long-term needs for patients in the United Kingdom.
The Department has also reached out to specialist importers who have sourced unlicensed stock to assist in covering the remaining gap in the market.
In the longer term, the Department has had interest from non-UK suppliers of PERT wishing to bring their products to the UK and, along with colleagues in the Medicine and Healthcare products Regulatory Agency, we are working with these potential suppliers, and if authorised, these products could further diversify and strengthen the market.
While the Department's approach for managing the supply issues with PERT is not specifically informed by the COVID-19 Vaccines Taskforce experience, as we are continually learning and seeking to improve the way we work to both manage and help prevent supply issues for PERT.
To ask His Majesty's Government, further to the Written Answer by Baroness Neville-Rolfe on 19 December 2023 (HL858), whether they have reviewed the account by Dame Kate Bingham in The Long Shot of her experience of government and other supervision whilst she was Chair of the UK Vaccine Taskforce; and what assessment...
To ask His Majesty's Government, further to the Written Answer by Baroness Neville-Rolfe on 19 December 2023 (HL858), whether they have reviewed the account by Dame Kate Bingham in The Long Shot of her experience of government and other supervision whilst she was Chair of the UK Vaccine Taskforce; and what assessment...
No assessment has been made of The Long Shot. The Government published A review of the Vaccine Taskforce on GOV.UK in an online-only format on 29 August 2023. The review draws out learning that can be applied to future Government programmes, both in emergency circumstances, and to business-as-usual activity.
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the UK's readiness for any future pandemic; and what assessment he has made of the potential impact on that readiness of the discontinuance of several of the initiatives of the UK Vaccine...
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the UK's readiness for any future pandemic; and what assessment he has made of the potential impact on that readiness of the discontinuance of several of the initiatives of the UK Vaccine...
The United Kingdom has flexible and well-tested pandemic response capabilities. We are continuously updating our pandemic plans to reflect the latest scientific information and lessons learned from exercises and our response to emergencies, including COVID-19. We cannot perfectly predict the characteristics of a new pandemic pathogen and therefore our pandemic preparedness is an area kept under constant review to ensure readiness.
The UK Vaccine Taskforce’s responsibilities including vaccine supply, onshoring of UK vaccine capability and international engagement are being integrated across Government functions including UK Health Security Agency. As part of our overall pandemic response capabilities the Government has in place an Advanced Purchase Agreement to guarantee access to pandemic specific influenza vaccines, which would likely be available within four to six months after the pandemic has started.
In addition, at the end of December, UK Government and Moderna entered a strategic partnership to set up mRNA research and development and manufacturing facilities in the UK, capable of producing up to 250 million vaccines per year in the event of a pandemic.
My Rt Hon Friend the Secretary of State for Health and Social Care (Steve Barclay) has made the following written statement:
The COVID-19 pandemic has shown the importance of having the ability to develop and deploy vaccines rapidly to respond to a health emergency, as well as to mitigate the...
My Rt Hon Friend the Secretary of State for Health and Social Care (Steve Barclay) has made the following written statement:
The COVID-19 pandemic has shown the importance of having the ability to develop and deploy vaccines rapidly to respond to a health emergency, as well as to mitigate the...
The COVID-19 pandemic has shown the importance of having the ability to develop and deploy vaccines rapidly to respond to a health emergency, as well as to mitigate the potential economic and health costs such an emergency can cause. It also demonstrated the need to establish resilience on UK shores...
The COVID-19 pandemic has shown the importance of having the ability to develop and deploy vaccines rapidly to respond to a health emergency, as well as to mitigate the potential economic and health costs such an emergency can cause. It also demonstrated the need to establish resilience on UK shores...
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of moving the Vaccine Taskforce into the UK Health Security Agency; and if he will make a statement.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of moving the Vaccine Taskforce into the UK Health Security Agency; and if he will make a statement.
On 1 October 2022, the core functions of the Vaccine Taskforce (VTF) merged with the UK Health Security Agency (UKHSA) and the Office for Life Sciences. The VTF’s vaccine supply responsibilities have moved to the UKHSA to establish a permanent function and staff have transferred to form a new directorate. This allows for the retention of the VTF’s innovative approaches, skills and operating models.
To ask the Secretary of State for Health and Social Care, what the expected annual (a) current and (b) capital expenditure on the Vaccines Taskforce will be in each financial year of that project; and if he will place that information in the House of Commons Library.
To ask the Secretary of State for Health and Social Care, what the expected annual (a) current and (b) capital expenditure on the Vaccines Taskforce will be in each financial year of that project; and if he will place that information in the House of Commons Library.
On 1 October 2022, the core functions of the Vaccine Taskforce (VTF) merged with the UK Health Security Agency and the Office for Life Sciences.
In February 2022, the National Audit Office confirmed that the VTF’s expenditure on vaccine development and procurement was £3.3 billion to the end of October 2021. In 2022/23, the Department has allocated £2 billion to procure and deploy COVID-19 vaccines
To ask the Secretary of State for Health and Social Care, what steps she is taking to integrate the UK Vaccine Taskforce into UKHSA.
To ask the Secretary of State for Health and Social Care, what steps she is taking to integrate the UK Vaccine Taskforce into UKHSA.
On 1 October 2022, the core functions of the UK Vaccine Taskforce (VTF) merged with the UK Health Security Agency (UKHSA) and the Office for Life Sciences. The vaccine supply responsibilities of the VTF have moved to the UKHSA to establish a permanent function. Staff from the VTF have moved into a new directorate within the UKHSA to ensure a smooth transition and embed learning from the VTF.
I am making this statement to bring to the House’s attention the following Machinery of Government change.
With effect from 1 August 2021, the Vaccine Taskforce will become a joint-unit of the Department for Business, Energy and Industrial Strategy and the Department of Health and Social Care.
To support this, responsibility for...
I am making this statement to bring to the House’s attention the following Machinery of Government change.
With effect from 1 August 2021, the Vaccine Taskforce will become a joint-unit of the Department for Business, Energy and Industrial Strategy and the Department of Health and Social Care.
To support this, responsibility for...
My Rt Hon Friend the Prime Minister has made the following statement:
I am making this statement to bring to the House’s attention the following Machinery of Government change.
With effect from 1 August 2021, the Vaccine Taskforce will become a joint-unit of the Department for Business, Energy and Industrial Strategy and...
My Rt Hon Friend the Prime Minister has made the following statement:
I am making this statement to bring to the House’s attention the following Machinery of Government change.
With effect from 1 August 2021, the Vaccine Taskforce will become a joint-unit of the Department for Business, Energy and Industrial Strategy and...
The vaccine taskforce has successfully brought together the collective effort of Government, academia and industry behind a single purpose and mission. Its hard work and focus, in partnership with the NHS and other organisations, helped the UK to become the first country to procure, authorise and deploy the Pfizer-BioNTech and Oxford-AstraZeneca vaccines. As I speak, over 30 million individuals across the UK have now received their first dose.
The vaccine taskforce has successfully brought together the collective effort of Government, academia and industry behind a single purpose and mission. Its hard work and focus, in partnership with the NHS and other organisations, helped the UK to become the first country to procure, authorise and deploy the Pfizer-BioNTech and Oxford-AstraZeneca vaccines. As I speak, over 30 million individuals across the UK have now received their first dose.
What lessons have been learned from the operation of the Vaccines Taskforce.
As the Secretary of State has rightly acknowledged, under his Department’s authorisation the vaccine taskforce has performed brilliantly, but it has needed a scientific and industrial base that was already there to work with. As he knows, there are some concerns about dependency on an overseas supply chain that may be interrupted. As the new Secretary of State, will he make a name for himself by challenging the dead hand of Treasury dogma and ensuring that Government contracts and projects across the board put British industry first at last?
As the Secretary of State has rightly acknowledged, under his Department’s authorisation the vaccine taskforce has performed brilliantly, but it has needed a scientific and industrial base that was already there to work with. As he knows, there are some concerns about dependency on an overseas supply chain that may be interrupted. As the new Secretary of State, will he make a name for himself by challenging the dead hand of Treasury dogma and ensuring that Government contracts and projects across the board put British industry first at last?
I am very pleased that the right hon. Gentleman is so enthusiastic about our British ingenuity and hard work. I and my right hon. Friend the Chancellor of the Exchequer are always working extremely hard and are very focused on trying to promote innovation in this country in our research and development base.
I am very pleased that the right hon. Gentleman is so enthusiastic about our British ingenuity and hard work. I and my right hon. Friend the Chancellor of the Exchequer are always working extremely hard and are very focused on trying to promote innovation in this country in our research and development base.
I am very pleased that the right hon. Gentleman is so enthusiastic about our British ingenuity and hard work. I and my right hon. Friend the Chancellor of the Exchequer are always working extremely hard and are very focused on trying to promote innovation in this country in our research and development base.
As the Secretary of State has rightly acknowledged, under his Department’s authorisation the vaccine taskforce has performed brilliantly, but it has needed a scientific and industrial base that was already there to work with. As he knows, there are some concerns about dependency on an overseas supply chain that may be interrupted. As the new Secretary of State, will he make a name for himself by challenging the dead hand of Treasury dogma and ensuring that Government contracts and projects across the board put British industry first at last?
The right hon. Gentleman has obviously been speaking to my officials because the issue has popped up on my desk this morning. We will not kick this into the long grass. We will tackle it. We will not allow bully boy tactics. We want a flexible workforce, but not at any cost.
The right hon. Gentleman has obviously been speaking to my officials because the issue has popped up on my desk this morning. We will not kick this into the long grass. We will tackle it. We will not allow bully boy tactics. We want a flexible workforce, but not at any cost.
The answer earlier that the Government would respond to the appalling fire and rehire in due course is Whitehall-speak for kicking it into the long grass, and it is not good enough. Will the Government learn from the methodology of their vaccine taskforce to move at speed, clarify the problem, identify a solution and make and rapidly implement decisions? Secretary of State, will you cut through the red tape and sort out this scandal? You may even make yourself popular.